Please check your internet connection and try again.
# Isoxsuprine hydrochloride
## Overview
Isoxsuprine hydrochloride is a vasodilator with some beta-adrenergic agonist activity. Its exact mechanism of action in improving intermittent claudication is not fully understood but is thought to involve peripheral vasodilation and possibly skeletal muscle relaxation.
## Primary Indications
Treatment of peripheral vascular disease, including arteriosclerosis obliterans, Buerger's disease, and Raynaud's disease. It has also been used to manage premature labor (tocolysis), though its use for this indication is largely unsupported by current evidence and not FDA-approved.
## Adult Dosing
* **Peripheral Vascular Disease:** The typical dose is 10 mg to 20 mg (one to two tablets) orally three to four times daily.
* Maximum dose: Not clearly established for peripheral vascular disease, but doses exceeding 120 mg daily are generally not recommended.
## Pediatric Dosing
No established pediatric dosing.
## Dose Adjustments
No specific dose adjustments are routinely recommended for hepatic or renal impairment. However, caution is advised.
## Contraindications
* Hypersensitivity to isoxsuprine hydrochloride.
* Do not administer intravenously.
## Adverse Effects
Common adverse effects include:
* Flushing
* Nausea
* Vomiting
* Dizziness
* Headache
* Hypotension (especially with rapid administration or high doses)
* Weakness
* Gastrointestinal distress
* Rash
## Key Drug Interactions
* **Antihypertensives:** May potentiate the hypotensive effects of antihypertensive medications.
* **Sympathomimetic agents:** May increase cardiovascular effects.
## Monitoring
* Blood pressure and pulse.
* Symptoms of peripheral vascular disease (e.g., walking distance, pain, paresthesia).
* Signs of adverse effects.
## Clinical Pearls
* Onset of action is typically within 30 minutes to 1 hour.
* Duration of action is generally 2 to 4 hours.
* Effectiveness in peripheral vascular disease is debated, and significant benefit is not consistently demonstrated.
* Oral administration is the only approved route.
***
*Disclaimer: This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information and relevant guidelines before making any clinical decisions. Dosing and recommendations may vary based on individual patient factors and local protocols.*
